Cargando…

Correction: Cholenic acid derivative UniPR1331 impairs tumor angiogenesis via blockade of VEGF/VEGFR2 in addition to Eph/ephrin

Detalles Bibliográficos
Autores principales:	Rusnati, Marco, Paiardi, Giulia, Tobia, Chiara, Urbinati, Chiara, Lodola, Alessio, D’Ursi, Pasqualina, Corrado, Miriam, Castelli, Riccardo, Wade, Rebecca C., Tognolini, Massimiliano, Chiodelli, Paola
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group US 2021
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9293753/ https://www.ncbi.nlm.nih.gov/pubmed/34593982 http://dx.doi.org/10.1038/s41417-021-00391-9

Ejemplares similares

Cholenic acid derivative UniPR1331 impairs tumor angiogenesis via blockade of VEGF/VEGFR2 in addition to Eph/ephrin
por: Rusnati, Marco, et al.
Publicado: (2021)

A Pharmacological Investigation of Eph-Ephrin Antagonism in Prostate Cancer: UniPR1331 Efficacy Evidence
por: Festuccia, Claudio, et al.
Publicado: (2023)

UniPR1331, a small molecule targeting Eph/ephrin interaction, prolongs survival in glioblastoma and potentiates the effect of antiangiogenic therapy in mice
por: Festuccia, Claudio, et al.
Publicado: (2018)

UniPR1331: Small Eph/Ephrin Antagonist Beneficial in Intestinal Inflammation by Interfering with Type-B Signaling
por: Giorgio, Carmine, et al.
Publicado: (2021)

Heparin and heparan sulfate proteoglycans promote HIV-1 p17 matrix protein oligomerization: computational, biochemical and biological implications
por: Bugatti, Antonella, et al.
Publicado: (2019)

Metabolic Soft Spot and Pharmacokinetics: Functionalization of C-3 Position of an Eph–Ephrin Antagonist Featuring a Bile Acid Core as an Effective Strategy to Obtain Oral Bioavailability in Mice
por: Ferlenghi, Francesca, et al.
Publicado: (2021)

HIV-1 Tat and Heparan Sulfate Proteoglycans Orchestrate the Setup of in Cis and in Trans Cell-Surface Interactions Functional to Lymphocyte Trans-Endothelial Migration
por: Urbinati, Chiara, et al.
Publicado: (2021)

Lithocholic Acid Is an Eph-ephrin Ligand Interfering with Eph-kinase Activation
por: Giorgio, Carmine, et al.
Publicado: (2011)

A Bittersweet Computational Journey among Glycosaminoglycans
por: Paiardi, Giulia, et al.
Publicado: (2021)

Molecular Determinants of EphA2 and EphB2 Antagonism Enable the Design of Ligands with Improved Selectivity
por: Guidetti, Lorenzo, et al.
Publicado: (2023)

Targeting the Eph/Ephrin System as Anti-Inflammatory Strategy in IBD
por: Grandi, Andrea, et al.
Publicado: (2019)

Polyanionic Drugs and Viral Oncogenesis: a Novel Approach to Control Infection, Tumor-associated Inflammation and Angiogenesis
por: Urbinati, Chiara, et al.
Publicado: (2008)

Protein-Protein Interaction Inhibitors Targeting the Eph-Ephrin System with a Focus on Amino Acid Conjugates of Bile Acids
por: Guidetti, Lorenzo, et al.
Publicado: (2022)

Recent Strategic Advances in CFTR Drug Discovery: An Overview
por: Rusnati, Marco, et al.
Publicado: (2020)

Evaluation of the Anti-Tumor Activity of Small Molecules Targeting Eph/Ephrins in APC (min)/J Mice
por: Corrado, Miriam, et al.
Publicado: (2020)

Heparin/Heparan Sulfate Proteoglycans Glycomic Interactome in Angiogenesis: Biological Implications and Therapeutical Use
por: Chiodelli, Paola, et al.
Publicado: (2015)

Theoretical Model of EphA2-Ephrin A1 Inhibition
por: Jedwabny, Wiktoria, et al.
Publicado: (2018)

The binding of heparin to spike glycoprotein inhibits SARS-CoV-2 infection by three mechanisms
por: Paiardi, Giulia, et al.
Publicado: (2021)

Virtual Drug Repositioning as a Tool to Identify Natural Small Molecules That Synergize with Lumacaftor in F508del-CFTR Binding and Rescuing
por: Fossa, Paola, et al.
Publicado: (2022)

The Role of Ephs and Ephrins in Memory Formation
por: Dines, Monica, et al.
Publicado: (2015)

Ephs and Ephrins in Adult Endothelial Biology
por: Vreeken, Dianne, et al.
Publicado: (2020)

The EPH/Ephrin System in Colorectal Cancer
por: Papadakos, Stavros P., et al.
Publicado: (2022)

Eph Receptors and Ephrins in Retinal Diseases
por: Kaczmarek, Radoslaw, et al.
Publicado: (2021)

Speeding Up the Identification of Cystic Fibrosis Transmembrane Conductance Regulator-Targeted Drugs: An Approach Based on Bioinformatics Strategies and Surface Plasmon Resonance
por: Rusnati, Marco, et al.
Publicado: (2018)

The molecular phylogeny of eph receptors and ephrin ligands
por: Mellott, Dan O, et al.
Publicado: (2008)

EPH-ephrin signaling in hyperoxia induced lunginjury
por: Lee, JM, et al.
Publicado: (2015)

Eph-ephrin signaling in nervous system development
por: Cramer, Karina S., et al.
Publicado: (2016)

Eph receptors and ephrins as targets for cancer therapy
por: Xi, Hong-Qing, et al.
Publicado: (2012)

Beyond boundaries—Eph:ephrin signaling in neurogenesis
por: Laussu, J, et al.
Publicado: (2014)

Ephrin-Eph signaling in embryonic tissue separation
por: Fagotto, Francois, et al.
Publicado: (2014)

The role of proteases in regulating Eph/ephrin signaling
por: Atapattu, Lakmali, et al.
Publicado: (2014)

Eph receptors and ephrins engage in cellular cannibalism
por: Pasquale, Elena B.
Publicado: (2019)

An Update on CFTR Drug Discovery: Opportunities and Challenges
por: D’Ursi, Pasqualina, et al.
Publicado: (2022)

Diverse Roles of Eph/ephrin Signaling in the Mouse Lens
por: Cheng, Catherine, et al.
Publicado: (2011)

The multifaceted roles of Eph/ephrin signaling in breast cancer
por: Kaenel, Philip, et al.
Publicado: (2012)

Regulation of contact inhibition of locomotion by Eph–ephrin signalling
por: BATSON, J, et al.
Publicado: (2013)

Emerging Roles for Eph Receptors and Ephrin Ligands in Immunity
por: Darling, Thayer K., et al.
Publicado: (2019)

Exosomes expand the sphere of influence of Eph receptors and ephrins
por: Pasquale, Elena B.
Publicado: (2016)

Harnessing the Power of Eph/ephrin Biosemiotics for Theranostic Applications
por: Hughes, Robert M., et al.
Publicado: (2020)

The Evolutionary History of Ephs and Ephrins: Toward Multicellular Organisms
por: Arcas, Aida, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_fksh85lkrrf329pmjlvjm4h3s8